Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

J&J Official Discusses How PGx Helps
Company Set ‘Realistic Expectations’

[December 12, 2007]

By Turna Ray

The drug maker uses PGx strategies in three principal ways: to strengthen its pharmacokinetics R&D programs, to improve drug safety and efficacy, and to select trial patients most likely to respond to its products.

Login | Subscribe